Results

Total Results: 9,462 records

Showing results for "cancer".
Users also searched for: colon cancer screening

241. Most Common Diagnoses and Procedures in U.S. Community Hospitals, 1996
     hcup-us.ahrq.gov/reports/natstats/commdx/table1g.htm
     February 11, 2011 - Secondary malignancies [42] 18,812 25.44 0.05 … Cancer of bronchus, lung [19] 4,338 5.87 0.01 … Other and unspecified benign neoplasm [47] 10,024 14.20 0.03 … Secondary malignancies [42] 5,706 8.08 0.02 … Other and unspecified benign neoplasm [47] 17,603 25.12 0.05

242. Statistical Brief #125
     hcup-us.ahrq.gov/reports/statbriefs/sb125.jsp
     February 01, 2012 - among men, breast cancers among women, and colorectal cancers among both men and women. … malignancies (i.e., metastatic cancer), and lung cancer. … cancer, secondary malignancies (i.e., metastatic cancers), and lung cancer (figure 1). … Stays for all other common cancers decreased. … malignancies 499,300 14.6% Cancer of bronchus, lung 389,200 11.3% Cancer of colon

243. Executive Summary - Nutrition as Prevention for Improved Cancer Outcomes: Comparative Effectiveness Review No. 260 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-260-improved-cancer-outcomes-executive-summary_0.pdf
     May 01, 2023 - Studies were predominately conducted in individuals with gastrointestinal and head and neck cancers, … predominately examined dietary supplements and nutrition support in gastrointestinal and head and neck cancers … Studies were predominately conducted in populations with gastrointestinal and head and neck cancers, … glutamine supplementation on the surgical outcome after pancreaticoduodenectomy for periampullary tumors … versus standard diet following McKeown minimally invasive esophagectomy in patients with esophageal malignancy

244. Evidence-based Practice Center Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-surveillance_research-protocol.pdf
     May 19, 2011 - The cancer is often localized, and most tumors have low histological grades and Gleason Scores. … half of them were expected to have early stage, low-risk tumors. 1 Thus, management of early stage … Tumor Characteristics i. Stage ii. Tumor volume iii. Gleason Score iv. PSA c. … In addition to prostate neoplasms/cancer, search terms will include “active surveillance,” “watchful … Definition of Terms TNM = Tumor stage, node involvement, and metastasis. VII.

245. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ghbfx9e3A6jQEqVW26y8Jv
     March 09, 2021 - harms Estimates were not provided for lifetime risk of radiation-induced cancers or fatal cancers from … across studies (range, 20%-80%) and by subgroups defined by clinical characteristics (eg, operability of tumor … test performance and interval cancers. … Lung-RADS category 4X: does it improve prediction of malignancy in subsolid nodules? … Extrapulmonary findings and malignancies in participants screened with chest CT in the National Lung

246. Final Research Plan: Prostate Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/prostate-cancer-screening-adults
     December 21, 2023 - or usual care on short- or long-term prostate cancer mortality, incidence of metastatic prostate cancer … of treatment vary in populations defined by age, race, ethnicity, family history, or Gleason grade/tumor … Do the harms vary in populations defined by age, race, ethnicity, family history, or Gleason grade/tumor … 1 , 2 have primarily detected early-stage cancer (90% to 96% of cancers detected). … screening and diagnostic workup; adding PSA density as a PSA-based screening approach; adding Gleason grade/tumor

247. Neds 2006V2 Maskedstats Core Weighted (pdf file)
     hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2006v2_MaskedStats_Core_Weighted.PDF
     January 01, 2019 - 965 0.00 29: Cancer of prostate 9582 0.01 30: Cancer of testis 890 0.00 31: Cancer of other male … ; other and unspecified primary 3604 0.00 42: Secondary malignancies 137580 0.11 43: Malignant neoplasm … without specification of site 4843 0.00 44: Neoplasms of unspecified nature or uncertain behavior 33568 … 0.03 45: Maintenance chemotherapy; radiotherapy 3698 0.00 46: Benign neoplasm of uterus 30192 0.03 … 47: Other and unspecified benign neoplasm 51580 0.04 48: Thyroid disorders 36347 0.03 49: Diabetes

248. Neds 2006 Maskedstats Core Weighted (pdf file)
     hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2006_MaskedStats_Core_Weighted.PDF
     January 01, 2006 - 1065 0.00 29: Cancer of prostate 9856 0.01 30: Cancer of testis 999 0.00 31: Cancer of other male … ; other and unspecified primary 3348 0.00 42: Secondary malignancies 134808 0.11 43: Malignant neoplasm … without specification of site 5032 0.00 44: Neoplasms of unspecified nature or uncertain behavior 32819 … 0.03 45: Maintenance chemotherapy; radiotherapy 3822 0.00 46: Benign neoplasm of uterus 31428 0.03 … 47: Other and unspecified benign neoplasm 51974 0.04 48: Thyroid disorders 38149 0.03 49: Diabetes

249. Draft Research Plan: Breast Cancer: Medication to Reduce Risk | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/breast-cancer-medication-use-reduce-risk
     December 28, 2023 - Share to Email Print in progress Draft Research Plan Breast Cancer … What is the effectiveness of risk-reducing medications on primary invasive breast cancer, breast cancer … What are the harms of medications used to reduce primary breast cancer risk? … (including tumor receptor status) and DCIS; breast cancer mortality; all-cause mortality; and quality … disorders Genitourinary outcomes Thromboembolic events Cardiovascular events Risk of other cancers

250. Management of Renal Masses and Localized Renal Cancer | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/renal-cancer/research-protocol

251. Modeling Study: Breast Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/modeling-study/breast-cancer-screening
     April 30, 2024 - cycles). 43-46 Based on published data, treatment benefit was therefore reduced by 28% for ER-negative tumors … Underlying incidence in the absence of screening and the proportion of tumors that were nonprogressive … Racial and ethnic differences in breast cancer survival: mediating effect of tumor characteristics and … for screening-detected and interval cancers. … 49, 50-64, 65-74, 75-89 y), screening round/interval (first, annual, biennial) for screen-detected cancers

252. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia_executive.pdf
     May 01, 2006 - (deficiency of red blood cells) occurs in 13-78 percent of patients undergoing treatment for solid tumors … Tumor type, treatment regimen, and history of prior cancer therapy influence the risk and severity of … For example, among patients with solid tumors, the frequency of anemia severe enough to require red blood … cell transfusion is highest for those with lung, gynecologic, and genitourinary tumors. … Whether erythropoietic stimulants accelerate progression of some cancers, as reported by one study (n

253. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer_executive.pdf
     May 01, 2010 - Layout 1 Background Head and neck cancers, specifically those arising in the oral cavity, larynx, … sinuses/nasal cavity, salivary glands, and occult primaries, account for approximately 3 to 5 percent of cancers … The main challenge in radiation therapy for cancer is to attain the highest probability of tumor control … Comparative Effectiveness Review Number 20 2 tumors for more than 50 years, it has been used mostly … short compared to some common cancers, such as breast or colon cancer.

254. Future Research Needs for Hematopoietic Stem-Cell Transplantation in the Pediatric Population (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children-future_research.pdf
     February 01, 2012 - • For single HSCT for high-risk Ewings sarcoma family of tumors, high-risk relapsed Wilm’s tumor, … and risk of second cancers in patients who have undergone stem cell transplant for cancer. … neoplasms. … LYSATE-PULSED DENDRITIC VACCINE FOR HIGH-RISK SOLID TUMORS A Pilot Study of Tumor Cell Vaccine … for High-risk Solid Tumor Patients Following Stem Cell Transplantation; University of Michigan Cancer

255. Final Research Plan: Breast Cancer: Medication to Reduce Risk | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/breast-cancer-medication-use-reduce-risk
     March 21, 2024 - Share to Email Print in progress Final Research Plan Breast Cancer … What is the effectiveness of risk-reducing medications on primary breast cancer, breast cancer mortality … What are the harms of medications used to reduce primary breast cancer risk? … (including tumor receptor status) and DCIS; breast cancer mortality; all-cause mortality; and global … disorders Genitourinary outcomes Thromboembolic events Cardiovascular events Risk of other cancers

256. Readmissions to U.S. Hospitals by Diagnosis, 2010 (pdf file)
     hcup-us.ahrq.gov/reports/statbriefs/sb153.pdf
     March 01, 2013 - Excludes cancers and nonspecific CCS categories. 4 Table 2. … Excludes cancers and nonspecific CCS categories. 5 Figure 1 shows that readmission rates … , other primary 6,146 1,781 29.0 42 Secondary malignancies 177,796 44,647 25.1 43 Malignant neoplasm … without specification of site 6,636 1,670 25.2 44 Neoplasms of unspecified nature or uncertain behavior … 42,002 9,551 22.7 45 Maintenance chemotherapy, radiotherapy 126,113 82,601 65.5 46 Benign neoplasm

257. Statistical Brief #153
     hcup-us.ahrq.gov/reports/statbriefs/sb153.jsp
     April 01, 2013 - Excludes cancers and nonspecific CCS categories. Table 2. … Excludes cancers and nonspecific CCS categories. … , other primary 6,146 1,781 29.0 42 Secondary malignancies 177,796 44,647 25.1 … 43 Malignant neoplasm without specification of site 6,636 1,670 25.2 44 Neoplasms … 9,551 22.7 45 Maintenance chemotherapy, radiotherapy 126,113 82,601 65.5 46 Benign

258. Aspirin or Nonsteroidal Anti-inflammatory Drugs for the Primary Prevention of Colorectal Cancer (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/c-7ARQE9RuXKjjpeLABkaH
     March 01, 2007 - More than 80% of colorectal cancers arise from adeno- matous polyps. … and has the second highest mortality rate among cancers, incidence is decreasing. … Annual report to the nation on the status of cancer (1973 through 1998), featur- ing cancers with recent … Low-dose aspirin and incidence of colorectal tumors in a randomized trial. … of nonsteroidal antiinflammatory drugs and other chemopreventors and risk of subsequent colorectal neoplasia

259. Archived: Ovarian Cancer: Screening, May 2004 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/ovarian-cancer-screening-2004
     May 04, 2004 - cohort studies using transvaginal ultrasound screening reported that 59 percent to 65 percent of ovarian cancers … were diagnosed in Stage I. 10 , 11 However, there is no evidence that detecting earlier-stage tumors … earlier treatment leads to a 40 percent mortality reduction) would yield a maximum of 4 additional cancers … American Cancer Society. Cancer Facts & Figures 2003 . … Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group.

260. Screening for Breast Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Pboxx4DR35wz5GPozm-XNF
     June 15, 2023 - review as stage IIB or higher, which encompasses tumors with local lymph node involvement or distant … No statistically signifi- cant differences were found in the cancer characteristics (tumor size, nodal … Proportion of Screen-Detected Invasive Cancers Diagnosed (Advanced Stage [II or Higher], Tumor Size > … 20 mm, Tumor Grade 3, Node-Positive Cancer) With Digital Breast Tomosynthesis vs Digital Mammography … Breast-cancer tumor size, overdiagnosis, and mammography screening effectiveness.